Management of diabetic neuropathy

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10% of diabetic patients after 5 years and in 15% after 20 years.Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.

Original languageEnglish
Pages (from-to)27-30
Number of pages4
JournalMalaysian Journal of Medical Sciences
Volume10
Issue number2
Publication statusPublished - Jul 2003

Fingerprint

Diabetic Neuropathies
Integumentary System
Urogenital System
Cardiovascular System
Diabetes Mellitus
Therapeutics

Keywords

  • Diabetes Mellitus
  • Management
  • Neuropathy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Management of diabetic neuropathy. / Ali, Raymond Azman.

In: Malaysian Journal of Medical Sciences, Vol. 10, No. 2, 07.2003, p. 27-30.

Research output: Contribution to journalArticle

@article{c7e1cc31e71b41f68811d39e906c0b81,
title = "Management of diabetic neuropathy",
abstract = "Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10{\%} of diabetic patients after 5 years and in 15{\%} after 20 years.Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.",
keywords = "Diabetes Mellitus, Management, Neuropathy",
author = "Ali, {Raymond Azman}",
year = "2003",
month = "7",
language = "English",
volume = "10",
pages = "27--30",
journal = "Malaysian Journal of Medical Sciences",
issn = "1394-195X",
publisher = "Universiti Sains Malaysia",
number = "2",

}

TY - JOUR

T1 - Management of diabetic neuropathy

AU - Ali, Raymond Azman

PY - 2003/7

Y1 - 2003/7

N2 - Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10% of diabetic patients after 5 years and in 15% after 20 years.Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.

AB - Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10% of diabetic patients after 5 years and in 15% after 20 years.Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.

KW - Diabetes Mellitus

KW - Management

KW - Neuropathy

UR - http://www.scopus.com/inward/record.url?scp=2642550609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642550609&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 27

EP - 30

JO - Malaysian Journal of Medical Sciences

JF - Malaysian Journal of Medical Sciences

SN - 1394-195X

IS - 2

ER -